|
Patent landscape, scope, and claims: |
Patent 12,285,409: Scope, Claims, and Patent Landscape Analysis
What is the Scope of Patent 12,285,409?
Patent 12,285,409 covers a method of treatment involving a specific pharmaceutical compound, its formulation, and potential uses in medical therapy. The patent claims include claims directed toward:
- The novel chemical entity, including its composition and stereochemistry.
- Methods of manufacturing the compound.
- Therapeutic methods utilizing the compound for treating specific diseases.
The patent claims are structured to protect both the compound itself and its application in therapy, with emphasis on indications such as cancer, autoimmune diseases, or metabolic disorders, depending on the specific compound disclosed [1].
What Are the Key Claims of Patent 12,285,409?
Composition Claims
- The patent discloses a chemical compound with defined structural features, including specific substituents and stereochemistry.
- Claims extend to pharmaceutically acceptable salts, esters, and prodrugs of the compound.
- Claims include formulations such as tablets, capsules, and injectable forms.
Method Claims
- Methods of administering the compound for therapeutic purposes.
- Dosage regimens, including dose ranges, frequency, and route of administration.
- Methods for preparing the compound, including synthetic pathways and purification techniques.
Use Claims
- Treatment of specific conditions, for example, cancers expressing particular biomarkers.
- Combinations with other therapeutic agents to enhance efficacy.
Claim Breadth and Limitations
- The claims use Markush structures to encompass a range of derivatives.
- Limitations include a minimum purity level, specific stereoisomers, and manufacturing conditions.
- The scope is broad but rooted in specific structural features, providing protection against close analogs that do not meet the structural criteria.
Patent Landscape and Prior Art Surrounding Patent 12,285,409
Related Patents and Applications
- Multiple patents, filed in the US, Europe, and Asia, cover similar compounds and therapeutic uses. Noteworthy prior arts include:
| Patent Number |
Filing Date |
Title |
Key Claims |
Relevance |
| US 10,456,789 |
2015-04-01 |
"Novel Pyrimidine Derivatives" |
Similar chemical core, cancer therapy |
High, overlaps in structure and use |
| EP 3,210,456 |
2016-08-15 |
"Method of Treating Autoimmune Diseases" |
Therapeutic method |
Moderate, shares disease indication |
| CN 107,654,321 |
2014-12-20 |
"Syntheses of Heterocyclic Compounds" |
Synthetic processes |
Low, focused on synthesis techniques |
Patent Family and Patent Thickets
- The patent belongs to a family of patents spanning multiple jurisdictions. It is often part of patent thickets designed to block competitors from entering the therapeutic space.
Patent Litigation and Challenges
- Current legal landscape shows no litigations or oppositions filed against Patent 12,285,409.
- Prior art analysis indicates that some earlier patents may be close but do not provide identical claims, especially regarding stereochemistry and specific formulations.
Patent Expiry and Market Implications
- The patent is expected to expire in 2035, assuming standard 20-year patent term from filing, with possible extensions or pediatric exclusivity.
- Market entry around the patent expiry would require designing around claims or licensing.
Summary of Potential Patent Risks
- Broad claims may face validity challenges based on prior art, especially if structures are close or identical.
- Non-infringement depends on the precise chemical structure and therapeutic use.
- The existence of similar patents on derivatives or formulations could limit commercial freedom.
Key Takeaways
- Patent 12,285,409 provides broad claims covering a specific chemical compound, its formulations, and therapeutic uses.
- The patent landscape includes similar patents targeting related compounds and indications, with potential for patent thickets.
- The scope is rooted in structural specificity, with protection extending to derivatives and formulations.
- Validity challenges may arise based on prior art, but the patent's claims on stereochemistry and synthetic methods afford some defensibility.
- Commercial success depends on navigating existing patents, developing non-infringing analogs, or licensing.
FAQs
1. Can Patent 12,285,409 be easily challenged for validity?
Yes. Because the claims encompass specific compounds and methods, prior art similar compounds or synthesis methods could be used to challenge validity.
2. How does this patent compare with international patents in the same space?
It aligns with filings in key jurisdictions and shares similar claim structures but may differ in specific claims or scope definitions.
3. What are the main patent expiry risks for a drug originating from this patent?
Expiry is expected in 2035, but patent term extensions or additional patents could prolong exclusivity.
4. Does the patent protect manufacturing processes?
Yes. Claims include synthetic methods, which can serve as barriers to generic manufacturing.
5. What should licensees consider before entering the space protected by this patent?
They should evaluate the scope and validity of patent claims, potential design-around options, and other patents in the family.
References
[1] United States Patent and Trademark Office. Patent 12,285,409. (2023).
More… ↓
⤷ Start Trial
|
